Incidence of Sepsis After Craniocerebral Operation
The Incidence and Outcome of Sepsis After Craniocerebral Operation
1 other identifier
observational
907
1 country
1
Brief Summary
To investigate the incidence and outcome of sepsis in critical patients undergoing craniotomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
December 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedFirst Posted
Study publicly available on registry
January 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedAugust 5, 2021
August 1, 2021
2 years
December 26, 2018
August 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of sepsis
The incidence of sepsis in critical patients undergoing craniotomy
28 days
Study Arms (2)
sepsis group
Patients have developed sepsis at ICU admission or during their ICU stay.
non-sepsis group
Patients do not develope sepsis at ICU admission or during their ICU stay.
Eligibility Criteria
All patients over 18 years of age and have undergone craniotomy in intensive care will be screened for sepsis at admission or during their ICU stay, whereas those who stay in the ICU for \<24 hrs for routine postoperative surveillance will be excluded.
You may qualify if:
- years or older
- ICU length of stay ≥ 24 hours
- after craniotomy
You may not qualify if:
- \<18 years
- ICU length of stay \< 24 hours
- Patients or their immediate family members refuse to participate in the research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jianfang Zhoulead
Study Sites (1)
Beijing Tian Tan hospital
Beijing, Beijing Municipality, 100050, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jian-Xin Zhou, MD
Beijing Tiantan Hospital, Capital Medical Universtity
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 26, 2018
First Posted
January 15, 2019
Study Start
January 1, 2017
Primary Completion
December 31, 2018
Study Completion
June 30, 2020
Last Updated
August 5, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share